In contrast to GAPDH (negative control) [32], selective association with GFP-MSI1 was also determined for the CD44 mRNA, supporting the conserved association of MSI1 and the CD44 mRNA in glioma-derived cell models. Here, CD44 is linked to central nervous system cancer.